メインコンテンツに移動
  • 認定パートナー
  • ELGAについて
    • ELGAについて
    • 採用情報
    • イベント
  • サポート
    • ラボのプランニング
    • 製品を登録
    • Register Your Product (USA & Canada Only)
  • お問い合わせ
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 中文
ホーム ELGA LabWater
  • 製品
    • PURELAB
    • CENTRA
    • MEDICA
    • BIOPURE
    • ELGA全製品ライン
  • 用途
    • ガスクロマトグラフィー
    • ラボ用水の一般要件
    • 免疫組織染色
    • 分光測光法
    • 原子分光学
    • 微生物学的分析
    • 液体クロマトグラフィー
    • 細胞培養
    • 臨床生化学
    • 質量分析
    • 遺伝学
    • 電気化学
  • 純水製造技術
    • PureSure
    • ろ過
    • イオン交換
    • 活性炭
    • 紫外線
    • 逆浸透(RO)
    • 電気脱イオン処理(EDI)
  • 水中の不純物
    • 微生物&細菌
    • 有機化合物
    • 溶存ガス
    • 無機化合物
    • 粒子状物質
  • Knowledge
    • ブログ
    • ケーススタディ
    • 超純水
    • ガイド&ホワイトペーパー
  • 製品
    • PURELAB
      • PURELAB® flex 1 & 2
      • PURELAB® flex 3 & 4
    • CENTRA
      • CENTRA® 60/120
      • CENTRA® RDS
      • CENTRA® R200
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® EDI 15/30
      • MEDICA® Pro EDI 60/120
      • MEDICA® Pro-LPS
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
    • BIOPURE
      • BIOPURE 7/15
      • BIOPURE 60/120
      • BIOPURE 200/300/600
    • ELGA全製品ライン
      • PURELAB® Classic
  • 用途
    • ガスクロマトグラフィー
    • ラボ用水の一般要件
    • 免疫組織染色
    • 分光測光法
    • 原子分光学
    • 微生物学的分析
    • 液体クロマトグラフィー
    • 細胞培養
    • 臨床生化学
    • 質量分析
    • 遺伝学
    • 電気化学
  • 純水製造技術
    • PureSure
    • ろ過
    • イオン交換
    • 活性炭
    • 紫外線
    • 逆浸透(RO)
    • 電気脱イオン処理(EDI)
  • 水中の不純物
    • 微生物&細菌
    • 有機化合物
    • 溶存ガス
    • 無機化合物
    • 粒子状物質
  • Knowledge
    • ブログ
      • Analytical Chemistry
      • Clinical & Pharma
      • Cool Science
      • Environment and sustainability
      • Life in the lab
      • Purelab product design
      • Science of the future
      • Water Purity
      • Water in the lab
    • ケーススタディ
      • 南アジアのAbbott Diagnostics、ELGA MEDICAシステムを選択
      • Beam Me Up, Scotty: PURELAB® Option Q Delivers Essential Ultra Pure Water
      • Clean Water for a Clean Future
      • Critital Tests Benefit from PURELAB® Option Reliable Pure Water
      • DASA:ブラジル最大の医療診断企業
      • 免疫血清学ラボの稼働時間最大化を支援するELGA
      • Fondazione Telethon Continues to Choose ELGA Labwater as a Trusted Partner
      • ジェネリック医薬品開発における超純水(I型水+)の重要性
      • Siemens ADVIA分析装置用に市立総合病院がMEDICA®Proを導入
      • Optimale Wasserqualität für mikrobiologische Forschung und Lehre
      • PURELAB® Option R Guarantees Pure Water for Leading Microfluidics Technology
      • PURELAB® Pulse Delivers Reliable Water Quality and Quantity for a Wide Range of Applications
      • PURELAB® flex:現代的な研究手法における理想的なトレーニングシステム
      • Powering Cutting-Edge Gene Research
      • Sichere Reinstwasserversorgung für präzise Produkttests
      • Zentrale Reinstwasser-Aufbereitung für Analyser
      • ELGA LabWater and Beckman Coulter Join Forces
      • Applied New Technologies Department Improves ICP, IC & HPLC Sample Turnaround Times with PURELAB®
      • 超純水により南極の謎を解明
      • Advancing Genetic Technologies
      • Cross Infection Control: Pure and Simple
      • Researching effective new ways to prevent cardiovascular disease at the University of Columbia
    • 超純水
    • ガイド&ホワイトペーパー
      • HPLC用水の純度
      • 製薬におけるHPLC
      • 臨床でのリスクの低減
      • サステナビリティ
  • English
  • Deutsch
  • Español
  • Français
  • Italiano
  • Português
  • 中文
  • プライバシーポリシー
  • 利用規約
  • 世界的な法令順守
  • 特許
  • サイト管理者情報
  • ホーム
  • Node
  • Identifying Anti-Viral Compounds In Chinese Medicinal Herbs
Clinical & Pharma
Cool Science

Identifying Anti-Viral Compounds In Chinese Medicinal Herbs

1 3月 2020
- by Dr Alison Halliday

Chinese Herbs

Using a new knowledge-based high-throughput screening strategy, researchers isolate three compounds with potent anti-viral activity from herbal extracts used in traditional medicine.

With people travelling more frequently and living in more densely populated areas, the potential for infectious diseases to spread rapidly and cause a pandemic is a major concern. Indeed, the serious global health threat posed by emerging viral infections is highlighted through recent outbreaks such as Ebola, Zika and Dengue.

The challenge is how to prepare for the future, since we don’t know when or where a new outbreak may occur – or the identity of the infectious agent. We need to build an arsenal of potent new anti-viral drugs to combat the risk of global pandemics with unpredictable viruses.

With around a third of all modern medicines are derived from natural products, many researchers are now turning to herbal remedies used in ancient medical practices as a source of new lead compounds for drug discovery.

Discovering Drugs From Traditional Medicines

Traditional Chinese Medicine (TCM) originated in ancient China and has evolved over thousands of years. Its practitioners use herbal medicines combined with various mind and body practices to treat or prevent health problems.

Herbal extracts used in TCM may contain a wealth of potentially valuable anti-viral compounds. But as most formulations contain a blend of multiple components, isolating an individual bioactive constituent is a daunting and labour-intensive process – with a low probability of success.

Integrating knowledge from ancient healing practices could help improve current high-throughput screening strategies – accelerating progress in discovering useful compounds from traditional herbal remedies.

Data-Driven Drug Discovery

A new study, published in Pharmacological Research, used a new ‘knowledge-based’ screening strategy and showed that this approach can efficiently identify anti-viral lead compounds from complex herbal extracts.1

The researchers systematically mined knowledge about herbal remedies and their therapeutic applications from the ‘Shanghan Zabing Lun’, an ancient TCM treatise containing over 200 formulations. Using a process of rational evaluation, they selected 24 formulations with potential anti-viral activity – and six more as negative controls. The team then used chromatography to separate these into fractions, creating a herbal extract library of 1,306 different components.

From Hit To Lead Compound

The team then screened each fraction for anti-viral activity using a high-throughput cell-based assay, identifying 18 components derived from seven ‘hit’ TCM formulations with different relieving effects on the symptoms of colds or influenza. Noticeably, none of the active components was derived from the six negative controls.

Using high-performance liquid-chromatography-mass spectrometry (HPLC/MS) Western blotting and immunofluorescence, the researchers went on to identify three lead compounds with potential anti-viral activity: ononin, sec-O-β-D-glucosylhamaudol and astragaloside I. 

The researchers used an ELGA PURELAB® laboratory water purification system to generate the ultrapure water that they used in their experiments.

A Powerful New Strategy

This study identifies three new promising anti-viral drug candidates and also provides proof-of-principle for an alternative screening approach for unearthing anti-viral lead compounds from TCM. This new targeted drug discovery approach could be extended to various cell-based models related to other diseases, helping to accelerate the process of identifying bioactive constituents from complex traditional formulations.

Why Choose ELGA LabWater?

ELGA’s expert engineers, chemists and scientists are at the forefront of technological innovation. We continue to introduce game-changing features to the laboratory water market.

 

Reference:

  1. Yu Y. et al. Ononin, sec-O-β-D-glucosylhamaudol and astragaloside I: anti-viral lead compounds identified via high throughput screening and biological validation from traditional Chinese medicine Zhongjing formulary. Pharmacol Res 2019; 145: 104248.

 

Dr Alison Halliday
After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

 

  • Enquiry
  • 見積もりを取得
  • デモを予約する
  • 承認されたパートナーを見つける

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

見積もりを取得

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

デモを予約する

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater本社

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
電話: +44 (0) 203 567 7300
ファックス:+44 (0) 203 567 7205

超純水スペシャリスト

  • サポート&サービス
  • イベント

ケーススタディ

  • Abbott Diagnostics(アボットダイアグノスティクス)
  • DASA Medical Diagnostics(DASA医療診断)
  • NeoDIN Medical Institute(NeoDIN医療機関)
  • UHNS(University Hospital of North Staffordshire NHS Trust/北スタンフォードシャア大学病院)
  • Olsberg Vocational College(オルスバーグ専門学校)

リソース

  • 超純水について
  • ガイド&ホワイトペーパー
  • 純水製造技術
  • 用途
  • 水中の不純物

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?
  • 言語
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • 他のVeoliaサイト
    • Veolia
    • Veolia Fondation
    • Veolia Water Technologies

©VWS(UK)Ltd.はELGA LabWaterとして取引されています。2021-全著作権所有。
ELGAはVeoliaのグローバルなラボ用水のブランド名です。

  • プライバシーポリシー
  • 利用規約
  • 世界的な法令順守
  • 特許
  • サイト管理者情報
Elga Veolia
TOP

© 2017 ELGA Veolia